Agenus Names Jean-Marie Cuillerot Head of Clinical Development

Agenus (NASDAQ: AGEN) has appointed Jean-Marie Cuillerot as its vice president and global head of clinical development. The Lexington, MA-based immuno-oncology company’s drug pipeline includes potential therapies for cancer, as well as shingles and malaria. Cuillerot’s cancer drug development experience includes posts at EMD Serono Research and Development Institute, Merck Serono, and Bristol-Myers Squibb (NYSE: BMY).

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at Follow @frankvinluan

Trending on Xconomy